Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Understanding fatigue in chronic liver disease

09.01.2006


A study examines new pathways linking liver disease to changes in the central nervous system



Liver disease is often associated with "sickness behaviors," such as malaise, listlessness, anorexia, difficulty concentrating, and fatigue. In cholestatic liver diseases (where bile production is impaired) such as primary biliary cirrhosis, fatigue occurs in up to 86 percent of patients. Previous studies have suggested that these symptoms originate from changes to the central nervous system (CNS), but little is understood about how these changes occur or the pathways involved.

In a study led by Steven M. Kerfoot of the Immunology Research Group at the University of Calgary in Canada and published in the January 2006 issue of Hepatology, researchers speculated that cholestatic liver damage may be associated with an immune response affecting the central nervous system, specifically the brain, which could represent a novel and potentially important pathway.


Hepatology, the official journal of the American Association for the Study of Liver Diseases (AASLD), published by John Wiley & Sons, Inc. is available online via Wiley InterScience at http://www.interscience.wiley.com/journal/hepatology.

The study involved creating cholestasis in mice by tying off the bile duct. Cerebral endothelial cells (cells lining the blood vessels of the brain) were then isolated and examined to see if they were activated, as activated endothelium tends to interact with activated immune cells. In addition, researchers analyzed TNF-alpha (a messenger protein involved in inflammation) production by monocytes, a type of white blood cell, to determine if a peripheral immune response was present.

The results showed an increase in TNF-alpha production by monocytes and activated endothelial cells in the cholestatic mice versus the control mice. The authors suggest that cholestasis is also associated with a broad activation of other immune cells within the central nervous system that produce TNF-alpha. "Given the significant behavioral effects of TNF-alpha within the CNS (i.e. sickness behaviors), the production of TNF-alpha within the brains of cholestatic mice is likely to be important in the alterations in behavior, as well as in the changes in the neurotransmitter systems which sub-serve these behaviors within the brains of cholestatic mice and may have direct implications for these systems in cholestatic patients," the authors conclude.

In an accompanying editorial in the same issue, Alexander I. Aspinall and David H. Adams of the Institute for Biomedical Research at the University of Birmingham in England, note the difficulties in treating fatigue associated with liver disease and the lack of understanding of the mechanisms that cause it, adding that the University of Calgary study "provides a novel mechanism to link cholestasis, inflammation and sickness behavior and is potentially important in understanding this poorly characterized aspect of chronic cholestasis." They state that the fact that monocytes were found in similar locations to those seen in inflammatory brain disease supports the likelihood that they are linked to pathological effects. However, they note that there are still unresolved issues in understanding sickness behaviors and that it remains unknown whether the results from the animal study will translate to cholestasis in humans. One key message from the study is that a number of factors most likely affect the CNS leading to sickness behaviors.

"Identifying the mediators involved is important not only to complete our understanding of the pathogenesis of sickness behaviors but also to inform the development of appropriate therapeutic agents," the authors state, adding that the risks of anti-TNF-alpha therapy most likely outweigh the potential benefits. They conclude: "It is to be hoped that a better understanding of these processes may lead to the development of more effective and rational therapies for this disabling symptom of cholestatic liver disease."

David Greenberg | EurekAlert!
Further information:
http://www.wiley.com

More articles from Health and Medicine:

nachricht Routing gene therapy directly into the brain
07.12.2017 | Boston Children's Hospital

nachricht New Hope for Cancer Therapies: Targeted Monitoring may help Improve Tumor Treatment
01.12.2017 | Berliner Institut für Gesundheitsforschung / Berlin Institute of Health (BIH)

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Scientists channel graphene to understand filtration and ion transport into cells

Tiny pores at a cell's entryway act as miniature bouncers, letting in some electrically charged atoms--ions--but blocking others. Operating as exquisitely sensitive filters, these "ion channels" play a critical role in biological functions such as muscle contraction and the firing of brain cells.

To rapidly transport the right ions through the cell membrane, the tiny channels rely on a complex interplay between the ions and surrounding molecules,...

Im Focus: Towards data storage at the single molecule level

The miniaturization of the current technology of storage media is hindered by fundamental limits of quantum mechanics. A new approach consists in using so-called spin-crossover molecules as the smallest possible storage unit. Similar to normal hard drives, these special molecules can save information via their magnetic state. A research team from Kiel University has now managed to successfully place a new class of spin-crossover molecules onto a surface and to improve the molecule’s storage capacity. The storage density of conventional hard drives could therefore theoretically be increased by more than one hundred fold. The study has been published in the scientific journal Nano Letters.

Over the past few years, the building blocks of storage media have gotten ever smaller. But further miniaturization of the current technology is hindered by...

Im Focus: Successful Mechanical Testing of Nanowires

With innovative experiments, researchers at the Helmholtz-Zentrums Geesthacht and the Technical University Hamburg unravel why tiny metallic structures are extremely strong

Light-weight and simultaneously strong – porous metallic nanomaterials promise interesting applications as, for instance, for future aeroplanes with enhanced...

Im Focus: Virtual Reality for Bacteria

An interdisciplinary group of researchers interfaced individual bacteria with a computer to build a hybrid bio-digital circuit - Study published in Nature Communications

Scientists at the Institute of Science and Technology Austria (IST Austria) have managed to control the behavior of individual bacteria by connecting them to a...

Im Focus: A space-time sensor for light-matter interactions

Physicists in the Laboratory for Attosecond Physics (run jointly by LMU Munich and the Max Planck Institute for Quantum Optics) have developed an attosecond electron microscope that allows them to visualize the dispersion of light in time and space, and observe the motions of electrons in atoms.

The most basic of all physical interactions in nature is that between light and matter. This interaction takes place in attosecond times (i.e. billionths of a...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

See, understand and experience the work of the future

11.12.2017 | Event News

Innovative strategies to tackle parasitic worms

08.12.2017 | Event News

AKL’18: The opportunities and challenges of digitalization in the laser industry

07.12.2017 | Event News

 
Latest News

PhoxTroT: Optical Interconnect Technologies Revolutionized Data Centers and HPC Systems

11.12.2017 | Information Technology

Large-scale battery storage system in field trial

11.12.2017 | Power and Electrical Engineering

See, understand and experience the work of the future

11.12.2017 | Event News

VideoLinks
B2B-VideoLinks
More VideoLinks >>>